140 related articles for article (PubMed ID: 23423786)
21. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
Larsson A; Johansson ME; Wangefjord S; Gaber A; Nodin B; Kucharzewska P; Welinder C; Belting M; Eberhard J; Johnsson A; Uhlén M; Jirström K
Br J Cancer; 2011 Aug; 105(5):666-72. PubMed ID: 21829192
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of BRCA1-associated protein 1 in colorectal cancer.
Tang J; Xi S; Wang G; Wang B; Yan S; Wu Y; Sang Y; Wu W; Zhang R; Kang T
Med Oncol; 2013 Jun; 30(2):541. PubMed ID: 23526420
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
24. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
[TBL] [Abstract][Full Text] [Related]
25. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer.
Büscheck F; Zub M; Heumann A; Hube-Magg C; Simon R; Lang DS; Höflmayer D; Neubauer E; Jacobsen F; Hinsch A; Luebke AM; Tsourlakis MC; Sauter G; Huland H; Graefen M; Haese A; Heinzer H; Schlomm T; Clauditz TS; Burandt E; Wilczak W; Steurer S; Minner S
Tumour Biol; 2019 Jul; 41(7):1010428318824815. PubMed ID: 31296150
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer.
Shen XG; Wang C; Li Y; Zhou B; Xu B; Yang L; Zhou ZG; Sun XF
Int J Colorectal Dis; 2011 Dec; 26(12):1519-24. PubMed ID: 21559821
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer.
He J; Li J; Feng W; Chen L; Yang K
Int J Clin Exp Pathol; 2015; 8(12):16007-13. PubMed ID: 26884876
[TBL] [Abstract][Full Text] [Related]
28. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
Tang K; Wang C; Chen Z; Xu H; Ye Z
Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
[TBL] [Abstract][Full Text] [Related]
30. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
31. MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease.
Tampakis A; Tampaki EC; Nonni A; Kontos M; Tsourouflis G; Posabella A; Fourie L; Bolli M; Kouraklis G; von Flüe M; Felekouras E; Nikiteas N
Oncology; 2021; 99(7):471-482. PubMed ID: 33853080
[TBL] [Abstract][Full Text] [Related]
32. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
Ma J; Chang W; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
[TBL] [Abstract][Full Text] [Related]
35. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
36. Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.
Song SH; Jeon MS; Nam JW; Kang JK; Lee YJ; Kang JY; Kim HP; Han SW; Kang GH; Kim TY
Oncogene; 2018 Feb; 37(8):993-1004. PubMed ID: 29106391
[TBL] [Abstract][Full Text] [Related]
37. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
Zheng L; Xie G; Duan G; Yan X; Li Q
PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
[TBL] [Abstract][Full Text] [Related]
40. High HSF4 expression is an independent indicator of poor overall survival and recurrence free survival in patients with primary colorectal cancer.
Yang Y; Jin L; Zhang J; Wang J; Zhao X; Wu G; Yao H; Zhang Z
IUBMB Life; 2017 Dec; 69(12):956-961. PubMed ID: 29131521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
